Can Blockchain Secure the Pharmaceutical Supply Chain?

 



Incidents of substandard or fraudulent pharmaceutical products still increase through what are assumed to be legitimate supply chains round the world. A recently released report by Organization for Economic Cooperation and Development (OECD) and therefore the european union property Office (EUIPO) estimates that international trade counterfeit pharmaceuticals reached USD 4.4 billion in 2016. These counterfeit medicines are believed to origin mostly in developing countries which will penetrate supply chains and make their thanks to anywhere within the world. This leaves regulators and distributors during a frenzy who struggle to locate substandard products that have entered the system. These potentially harmful products pose serious risk to the health of many patients who buy and consume these medicines believing that they're safe and effective.

To address a number of these supply chain challenges, the pharmaceutical industry is popping to blockchain technology to enhance its visibility and potentially enhance patient safety.


What is Blockchain?

Blockchain may be a public ledger technology that gives an immutable record of transactions.

It maintains a continuously growing set of knowledge , by logging data entries during a decentralised manner then combining the discrete blocks of knowledge from various stakeholders which upon acceptance are linked to the previous and future blocks. it's readable, writable, and tamper-proof by all. No central authority can control the content added and it's impossible to get rid of any entries after being accepted into the blockchain. It thus allows for transparency while maintaining data privacy. Immutability of the info enables the technology to be considered for highly regulated industries like pharmaceuticals and healthcare.

Using this advanced technology, several companies which will include a whole network of suppliers, producers, distributors, retailers, etc. can safely collaborate employing a shared ledger while maintaining complete control and confidentiality. This helps all the members of the network to manage the info without the presence of any third party.


How Can It Help the Pharmaceutical Industry?

Pharmaceutical supply chains are highly complex and involve various stakeholders that range from manufacturers, suppliers, distributors, to regulatory agencies, hospitals, retailers who collaborate to collectively produce and deliver drug products. it's important that the availability chain although complex be flexible and responsive enough to swiftly introduce new products to the market, especially during a crisis just like the one we face immediately when timely distribution of life-saving drugs becomes all the more important and necessary.

Blockchain technology can effectively help manufacturers secure the standard of every ingredient, make sure the timely shipping of materials and maintenance of optimal storage conditions. Blockchain-based supply chain containing IoT devices, smart contracts, distribution ledger, and business layers can generate data for monitoring the standard of the assets, handle the privacy of knowledge , and predict the end-user requirements.

It not only introduces transparency in supply chain among the relevant stakeholders but also accelerates the general process of the delivery of medicine to patients. Blockchain can greatly help improve the agility of the availability chain even during extraordinary circumstances to expedite the availability of essential medicines. Enabling real–time verification by confirming transactions without having to seem at the underlying data, it also can smoothen day-to-day operations. Pharmaceutical companies affect sensitive information. With blockchain technology, the confidentiality of such information are often well-protected.

This technology can significantly reduce costs, automate processes by eliminating manual interventions and help save the pharmaceutical industry billions of dollars annually. To sum up, using blockchain technology can immensely benefit pharmaceutical supply chain by offering end-to-end visibility, control, enhanced agility, and transparency. most significantly , blockchain technology creates an ecosystem of all stakeholders where they will collaborate, freely communicate, and operate seamlessly.


The Road Ahead

With further development of the technology and successful adoption of it, pharmaceutical companies along side other relevant supply and distribution stakeholders could precisely detect blockages within the supply chain, and take away damaged or counterfeit products, effectively identify which products face shortages or which areas have poor supply and redistribute inventory wherever it's most required.

All through the COVID crisis the pharmaceutical industry has had tremendous pressure to take care of its operational continuity ensuring fast and continuous supply of medicines even during these challenging circumstances. the worldwide health crisis actually reinstated our dependence on the pharmaceutical industry. it's therefore a chance for the industry to reimagine its processes and adopt the technology which will significantly help it in operating seamlessly.


References

https://pharma-trends.com/2020/11/23/can-blockchain-secure-the-pharmaceutical-supply-chain/


Pharmaceutical Solutions

Website:

https://www.acg-world.com/



Comments

Post a Comment

Popular posts from this blog

Because patients always come first - Pharmaceutical Solutions

Image
  Patients  lately  are more well-informed than ever.  because of  today’s technological and scientific advances, which have made access to information quick  and straightforward  . With patients and consumers increasingly becoming more empowered, the pharma industry must embrace opportunities to adopt more patient-centred approaches. Beyond the pill Patients now seek holistic health solutions, which are  quite  just the pill and  specialise in  quality, convenience, and cost. Engaging with patients and  taking note of  their voice has become crucial for ensuring future success. Patients are now being recognised as important stakeholders  within the  health care dialogue as regulatory health authorities (such  because the  US Food and Drug Administration and European Medicines Agency EMA) are requesting patient inputs into their  deciding . Patient centricity as  an idea  isn't  ...
Read more

Advances in the oral delivery of protein and peptide therapeutics

Image
  Recent advancements in biologics have unleashed tremendous opportunities in addressing unmet medical needs taking healthcare to new heights. Biologics have shown promising  leads to  the treatment of debilitating conditions  like  diabetes, cancer, autoimmune diseases that affect millions worldwide. The success biologics  are often  attributed to their high specificity and enhanced therapeutic potential over conventional small molecules. It should come as no surprise then  that almost  80% of the novel drugs approved by the US FDA in 2020 constituted of biologics. Currently,  quite  800 peptide drugs are  within the  pipeline and around 197 peptide-based drugs  are  commercialised.  the worldwide  biologics market stood at an estimated USD 269,152 million in 2019 and  is predicted  to grow at a CAGR of 14.7%  to succeed in  up to USD 464,604 million by 2023. Asia-Pacific  espe...
Read more

Flexible Pharma Manufacturing – Need of the Hour

Image
Times are changing, and with it, the ways the pharma industry  wont to  operate  also are  changing. The so–called ‘’conservative’’ pharma manufacturers are now looking beyond  the normal  manufacturing model, exploring new avenues to accommodate unexpected sales forecasts  and little  volume production. As novel drug delivery therapies are evolving with time, pharma manufacturers now need manufacturing capabilities that are versatile enough to accommodate the market’s uncertain requirements and are more responsive. Flexible manufacturing is emerging as apt solution  which will  overcome these challenges successfully. Why flexible manufacturing Traditional manufacturing setup comprising different equipment pieces  for various  processes  are not any  longer enough  to satisfy  the assembly  requirements  of latest  drug products with small volume. Not only  is that this  mode in...
Read more